PLS1 polyclonal antibody, anti-human, mouse, rat

Background:
cofactor:Calcium.,May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. May play a central role in the initiation of fibrin clot formation, in the activation of mast cells and in the recognition of apoptotic and injured cells by the reticuloendothelial system.,May play a role in the antiviral response of interferon (IFN) by amplifying and enhancing the IFN response through increased expression of select subset of potent antiviral genes. May contribute to cytokine-regulated cell proliferation and differentiation.,induction:By phosphorylation by PKC. Induced by INFB1 in response to a viral infection.,online information:Scramblase entry,PTM:Known to be palmitoylated at one, yet undefined, site.,Belongs to the phospholipid scramblase family.,subunit:Interacts with ABL.,tissue specificity:Expressed in platelets, erythrocyte membranes, lymphocytes, spleen, thymus, prostate, testis, uterus, intestine, colon, heart, placenta, lung, liver, kidney and pancreas. Not detected in brain and skeletal muscle.,

Research Area: Cardiovascular, Microbiology, Signal transduction

Synonyms: Phospholipid scramblase 1 , PL scramblase 1, Ca, 2+-dependent phospholipid scramblase 1, Erythrocyte phospholipid scramblase, MmTRA1b

Immunogen: The antiserum was produced against synthesized peptide derived from human AMPK alpha around the phosphorylation site of Thr172. AA range:140-189

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Formulation: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Concentration: 1 mg/ml

Storage:
-20°C for 1 year